Perrigo (PRGO) Net Cash Flow Growth (3y) (2016 - 2026)
Perrigo (PRGO) Net Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -28.90% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -5.41% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.55% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 95.24% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -106.21% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 4.40% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.73% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Perrigo | 1.93 Bn | 1.53 Bn | 313.90 Mn | 656.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 656.54% |
| Mar 28, 2026 | -49.86% |
| Dec 31, 2025 | -6.33% |
| Sep 27, 2025 | -62.05% |
| Jun 28, 2025 | 26.26% |
| Mar 29, 2025 | -54.54% |
| Dec 31, 2024 | -62.36% |
| Sep 28, 2024 | -19.81% |
| Jun 29, 2024 | 7.86% |
| Mar 30, 2024 | 18.42% |
| Dec 31, 2023 | 38.32% |
| Sep 30, 2023 | 27.67% |
| Jul 1, 2023 | -25.99% |
| Apr 1, 2023 | -32.28% |
| Dec 31, 2022 | 64.24% |
| Oct 1, 2022 | 80.73% |
| Jul 2, 2022 | -105.25% |
| Apr 2, 2022 | -31.77% |
| Dec 31, 2021 | -56.08% |
| Oct 2, 2021 | 185.38% |